Comparison of Blood Glucose Values on Admission for Acute Myocardial Infarction in Patients With Versus Without Diabetes Mellitus

American Journal of Cardiology

Volumn 104, Issue 6, 2009, Pages 769-774

  Ishihara, Masaharu ^a   Kojima, Sunao ^a   Sakamoto, Tomohiro ^b   Kimura, Kazuo ^d   Kosuge, Masami ^d   Asada, Yujiro ^e   Tei, Chuwa ^f   Miyazaki, Shunichi ^h   Sonoda, Masahiro ^g   Tsuchihashi, Kazufumi ^j   Yamagishi, Masakazu ^k   Shirai, Mutsunori ^l   Hiraoka, Hisatoyo ⁱ   Honda, Takashi ^b   Ogata, Yasuhiro ^c   Ogawa, Hisao ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b SAISEIKAI KUMAMOTO HOSPITAL   (Japan)

^c JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

^d YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^e UNIVERSITY OF MIYAZAKI   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION KAGOSHIMA MEDICAL CENTER   (Japan)

^h KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

ⁱ OSAKA UNIVERSITY   (Japan)

^j SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^k KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^l YAMAGUCHI UNIVERSITY   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; JAPAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; DIABETIC ANGIOPATHIES; FEMALE; HOSPITAL MORTALITY; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SURVIVAL ANALYSIS;

EID: 69549104728     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.04.055     Document Type: Article

References (29)

1. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycemia and increased risk after myocardial infarction in patients without diabetes: a systematic overview. Lancet 355 (2000) 773-778
2. Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., Cox J.L., and ICONS Investigators. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
3. Stranders I., Diamant M., van Gelder R.E., Spruijt H.J., Twisk J.W., Heine R.J., and Visser F.C. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164 (2004) 982-988
4. Kosiborod M., Rathore S.S., Inzucchi S.E., Masoudi F.A., Wang Y., Havranek E.P., and Krumholz H.M. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
5. Ishihara M., Kojima S., Sakamoto T., Asada Y., Tei C., Kimura K., Miyazaki S., Sonoda M., Tsuchihashi K., Yamagishi M., Ikeda Y., Shirai M., Hiraoka H., Inoue T., Saito F., Ogawa H., and Japanese Acute Coronary Syndrome Study (JACSS) Investigators. Acute hyperglycemia is associated with adverse outcome after acute myocardial infarction in the coronary intervention era. Am Heart J 150 (2005) 814-820
6. Svensson A.M., McGuire D.K., Abrahamsson P., and Dellborg M. Association between hyper- and hypoglycaemia and 2 year all-cause mortality risk in diabetic patients with acute coronary events. Eur Heart J 26 (2005) 1255-1261
7. Kosiborod M., Inzucchi S.E., Krumholz H.M., Xiao L., Jones P.G., Fiske S., Masoudi F.A., Marso S.P., and Spertus J.A. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117 (2008) 1018-1027
8. Pinto D.S., Skolnick A.H., Kirtane A.J., Murphy S.A., Barron H.V., Giugliano R.P., Cannon C.P., Braunwald E., Gibson C.M., and TIMI Study Group. U-shaped relationship of blood glucose with adverse outcomes among patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 46 (2005) 178-180
9. Deedwania P., Kosiborod M., Barrett E., Ceriello A., Isley W., Mazzone T., and Raskin P. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association diabetes committee of the council on nutrition, physical activity, and metabolism. Circulation 117 (2008) 1610-1619
10. Matsuo S., Imai E., Horio Y., Yasuda Y., Tomita K., Nitta K., Yamagata K., Tomino Y., Yokoyama H., Hishida A., and collaborators for developing Japanese equation for estimating GFR. Revised equation for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53 (2009) 982-992
11. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nishioka Y., Nakamura Y., and Yoshida M. Effect of acute hyperglycemia on the ischemic preconditioning effect of prodromal angina pectoris in patients with an anterior wall first acute myocardial infarction. Am J Cardiol 92 (2003) 288-291
12. Ceriello A., Quagliaro L., D'Amico M., Di Filippo C., Marfella R., Nappo F., Berrino L., Rossi F., and Giugliano D. Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 51 (2002) 1076-1082
13. Williams S.B., Goldfine A.B., Timimi F.K., Roddy M.A., Simonson D.C., and Creager M.A. Acute hyperglycemia attenuates endothelium-dependent vasodilation in human in vivo. Circulation 97 (1998) 1695-1701
14. Worthley M.I., Holmes A.S., Willoughby S.R., Kucia A.M., Heresztyn T., Stewart S., Chirkov Y.Y., Zeitz C.J., and Horowitz J.D. The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes. J Am Coll Cardiol 49 (2007) 304-310
15. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycemia and therapeutic prospects. Diabetologia 36 (1993) 1119-1125
16. Iwakura K., Ito H., Ikushima M., Kawano S., Okamura A., Asano K., Kuroda T., Tanaka K., Masuyama T., Hori M., and Fujii K. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41 (2003) 1-7
17. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Nishioka K., Kouno Y., Umemura T., Nakamura T., and Yoshida M. Impact of acute hyperglycemia on left ventricular function after reperfusion therapy in patients with a first anterior wall acute myocardial infarction. Am Heart J 146 (2003) 674-678
18. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., and Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106 (2002) 2067-2072
19. Monnier L., Mas E., Ginet C., Michel F., Villon L., Cristol J.P., and Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295 (2006) 1681-1687
20. Feuvray D., and Lopaschuk G.D. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res 34 (1997) 113-120
21. Desouza C., Salazar H., Cheong B., Murgo J., and Fonseca V. Association of hypoglycaemia and cardiac ischaemia: a study based on continuous monitoring. Diabetes Care 26 (2003) 1485-1489
22. Depre C., Vanoverschelde J.L.J., and Taegtmeyer H. Glucose for the heart. Circulation 99 (1999) 578-588
23. Kahn B.B. Facilitative glucose transporters: regulatory mechanisms and dysregulation in diabetes. J Clin Invest 89 (1992) 1367-1374
24. Opie L.H. Metabolic perturbations in ischemic heart disease. Dialogues Cardiovasc Med 2 (1996) 75-82
25. Malmberg K., Rydén L., Efendic S., Herlitz J., Nicol P., Waldenström A., Wedel H., Welin L., and DIGAMI study group. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effect on mortality at 1 year. J Am Coll Cardiol 26 (1995) 57-65
26. The CREATE-ECLA Trial Group. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. The CREATE-ECLA randomized controlled trial. JAMA 293 (2005) 437-446
27. Mellbin L.G., Malmberg K., Norhammar A., Wedel H., Rydén L., and DIGAMI 2 Investigators. The impact of glucose lowering treatment on long-term prognosis in patients with type 2 diabetes and myocardial infarction: a report from the DIGAMI 2 trial. Eur Heart J 29 (2008) 166-176
28. Norhammar A.T.Å., Nilsson G., Hamsten A., Efendíc S., Rydén L., and Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359 (2002) 2140-2144
29. Ishihara M., Inoue I., Kawagoe T., Shimatani Y., Kurisu S., Hata T., Nakama Y., Kijima Y., and Kagawa E. Is admission hyperglycemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance?. Eur Heart J 27 (2006) 2413-2419